Zhongsong Zhang
机构:China National Nuclear Corporation, Chengdu Medical College, First Affiliated Hospital of Chengdu Medical College, Chengdu Second People's Hospital · ORCID:0009-0009-9465-6425
发表论文 31 篇 · 总被引 135 次 · h-index 8
代表论文
- Regulation of oxidative stress and inflammation caused by drug accumulation in the TME based on EPR-passive strategy and active targeting (2025 · Cancer Nanotechnology · 被引 23)
- Current insights and trends in atopic dermatitis and microbiota interactions: a systematic review and bibliometric analysis (2025 · Frontiers in Microbiology · 被引 13)
- Targeting Cancer-Associated Fibroblasts in Prostate Cancer: Recent Advances and Therapeutic Opportunities (2025 · Cancers · 被引 9)
- Nanomaterials for Theranostic Management of Oral Cancer: Advances in Imaging, Biosensing, Targeted Delivery, and Multimodal Synergistic Therapy (2025 · International Journal of Nanomedicine · 被引 8)
- The Neuroimmune Axis in Atopic Dermatitis: From Pathogenic Mechanisms to Targeted Neuroimmunotherapy (2025 · Journal of Inflammation Research · 被引 6)
- Nanomedicine Targeting Cancer-Associated Fibroblasts in Prostate Cancer: From Biological Mechanisms to Integrated Theranostic Strategies (2026 · International Journal of Nanomedicine · 被引 3)